U.S. health officials briefing Congress on Wednesday would not outline a timeframe for when enough H1N1 (swine flu) vaccines would be available to reach all high-risk populations in the country, the Washington Post reports.
Pneumonia & Flu
“Two million of the world’s poorest children could be saved by introducing routine vaccination programs against diarrhea and pneumonia,” according to a new report (.pdf) from UNICEF, BBC News reports (6/8). “Pneumonia and diarrhea account for nearly one-third of the deaths among children under five globally,” the Guardian writes, adding, “Nearly 90 percent of deaths from pneumonia and diarrhea occur in sub-Saharan Africa and South Asia” (Tran, 6/8). The report “identifies a tremendous opportunity to narrow the child survival gap both among and within countries by increasing commitment, attention and funding,” according to a press release from UNICEF (6/8).
Noting that the journal Science last week published the second of two controversial bird flu research papers, in which a team led by Ron Fouchier of the Erasmus Medical Center in Rotterdam created a mutated strain of the virus that spreads easily among ferrets, a Washington Post editorial writes that “this is not the end of the story. Rather, it marks the beginning of an important chapter for both science and security.” The editorial continues, “The United States and other nations need a more sophisticated process for vetting research for possible security threats without discouraging or impairing scientists,” adding, “This is more difficult than it sounds.”
Congressman 'Dissatisfied' With Handling Of Controversial H5N1 Papers Calls For Cohesive Policy For Handling 'Risky' Research
“[D]issatisfied with the government’s handling of two research papers on mutant forms of avian influenza,” Rep. Jim Sensenbrenner (R-Wisc.) on Wednesday “said that the lack of a cohesive policy for handling risky research funded by the National Institutes of Health (NIH) and other federal agencies could necessitate new laws, a situation that researchers have been trying to avoid,” the Nature News Blog reports. “The second of the controversial papers showing that H5N1, or ‘bird flu,’ can spread through the air between mammals was published last week, providing some closure to the months-long debate about the work and whether its publication would result in the proliferation of dangerous viruses and increased risk of an accidental or intentional release,” the blog writes, adding, “Sensenbrenner says not enough work has been done to ensure that such controversies don’t arise again.”
The U.S. journal Science on Thursday published the results of a controversial study in which researchers at the Erasmus Medical Center in the Netherlands “identified five mutations apparently necessary to make the [H5N1] bird flu virus spread easily among ferrets, which catch the same flus that humans do,” the New York Times reports (McNeil, 6/21). “The publication of [the] research had been delayed by several months after the U.S. government’s National Science Advisory Board for Biosecurity (NSABB) warned that the information should be censored to avoid being misused, for example by terrorists,” the Guardian writes, noting, “Last month, Yoshihiro Kawaoka at the University of Wisconsin-Madison published details of another form of the bird flu virus that can pass between people, which was created by merging a mutated strain with the swine flu virus that sparked a human pandemic in 2009” (Jha, 6/21).
“It’s easy to get the impression that [recent controversy over research into mutated versions of the H5N1 flu virus] has created a clear split between a scientific community that wants the research to proceed and the results to be published and a biosecurity community that doesn’t,” biological-weapons expert Tim Trevan writes in this Nature opinion piece. But “[a]s a member of this biosecurity community for more than 30 years — I was special adviser to the chairman of the United Nations weapons inspectors in Iraq and covered chemical and biological disarmament with the U.K. Foreign Office in both London and Geneva, Switzerland — I believe this to be a false dichotomy,” he states.
Interventions Aimed At Preventing, Treating Pneumonia In Children Need To Be Expanded In Developing World
“This month, USAID’s flagship Maternal and Child Health Integrated Program (MCHIP) joins countries around the world in celebrating International Children’s Day,” Dyness Kasungami, a child health team leader for MCHIP, writes in the Huffington Post Blog, adding, “While great strides in child survival have been made in the past years, we also remember those children who do not live to see their fifth birthday — the 7.6 million children who die of preventable causes each year.” She notes, “Pneumonia is the leading cause of death in children under five, killing 1.4 million children each year, more than tuberculosis, AIDS, and malaria combined,” and continues, “Children can be protected from pneumonia through behavioral interventions such as adequate nutrition during childhood, hand washing, and reducing indoor air pollution by using improved, well-ventilated stoves.”
“Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years,” researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health write in a new commentary featured in the June issue of the Journal of the American Medical Association,” a Johns Hopkins press release reports. In the commentary, “researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths,” the press release notes (6/14).
Also In Global Health News: Malaria Drugs In Kenya; Dengue Epidemic In Caribbean; Kenya’s Controversial Draft Constitution; UN Women Budget
Kenya To Benefit From Deal To Cut Malaria Drug Prices In Half Business Daily reports that “Kenyans are set to benefit from a major deal that is likely to cut prices of malaria drugs by more than half, easing the pressure on family medical costs.” The deal involves the Global…
Also In Global Health News: WHO Flu Response; Sanitation In Mozambique; Interfaith HIV/AIDS Summit; HIV/AIDS In Uganda; South African Hospital Renovations; HIV Vaccine Development
Chan Defends WHO’s Response To H1N1 On Tuesday, WHO Director-General Margaret Chan defended her agency’s response to the H1N1 flu pandemic saying, “I personally do not believe that WHO exaggerated the threat,” and that “[a] new disease is, by definition, poorly understood as it emerges,” Reuters reports. Chan continued, “Had…